Corrigendum to “Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines” [Int. J. Biochem. Cell Biol. 38 (2006) 1584–1593] (International Journal of Biochemistry & Cell Biology (2006) 38(9) (1584–1593), (S1357272506001075), (10.1016/j.biocel.2006.03.019));Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 9, 2006, Pages 1584-1593

  Jia, Li ^a   Wang, Shujing ^a   Zhou, Huimin ^a   Cao, Jun ^a   Hu, Yichuan ^a   Zhang, Jianing ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Caveolin 1; CD147; Glycosylation; Invasion; MMP 11

Indexed keywords

CAVEOLIN 1; CD147 ANTIGEN; GELATINASE A;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; LIVER CELL; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RNA INTERFERENCE; UPREGULATION;

MURINAE;

EID: 33646556449     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2021.105980     Document Type: Erratum

References (39)

1. Basset P., Wolf C., Rouyer N., and Bellocq J.P. Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer 74 (1994) 1045-1049
2. Bender F.C., Reymond M.A., Bron C., and Quest A.F. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Research 60 (2000) 5870-5878
3. Biswas C., Zhang Y., DeCastro R., Guo H., Nakamura T., Kataoka H., et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Research 55 (1995) 434-439
4. Burgermeister E., Tencer L., and Liscocitch M. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene 22 (2003) 3888-3900
5. Cohen A.W., Hnasko R., Schuber W., and Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiological Reviews 84 (2004) 1341-1379
6. Deng H., Guo R.F., Li W.M., Zhao M., and Lu Y.Y. Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells. BBRC 14 (2005) 274-281
7. Duffy M.J., Maguire T.M., Hill A., McDermott E., and O'Higgins N. Metalloproteinases: Role in breast carcinogenesis, invasion and metastasis. Breast Cancer Research 2 (2000) 252-257
8. Fong A., Garcia E., Gwynn L., Lisanti M.P., Fazzari M.J., and Li M. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. American Journal of Clinical Pathology 120 1 (2003) 93-100
9. Fujimoyo T., Kogo H., Nomura R., and Une T. Isoforms of caveolin-1 and caveolar structure. Journal of Cell Science 113 19 (2000) 3509-3517
10. Ho C.C., Huang P.H., Huang H.Y., Chen Y.H., Yang P.C., and Hsu S.M. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. American Journal of Pathology 161 (2002) 1647-1656
11. Horiguchi A., Asano T., Asakuma J., Asano T., Sumitomo M., and Hayakawa M. Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma. Journal of Urology 172 (2004) 718-722
12. Ishibashi Y., Matsumoto T., Niwa M., Suzuki Y., Omura N., Hanyu N., et al. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer 101 9 (2004) 1994-2000
13. Johnson L.D., Hunt D.M., Kim K., and Nachtigal M. Amplification of stromelysin-3 transcripts from carcinomas of the colon. Human Pathology 27 (1996) 964-968
14. Kim H.P., Wang X., Nakao A., Kim S.I., Murase N., Choi M.E., et al. Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proceedings of the National Academy of Science, USA 102 32 (2005) 11319-11324
15. Liang Q., Xiong H., Gao G., Xiong K., Wang X., Zhao Z., et al. Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis. Cancer Biology and Therapy 4 7 (2005) 759-762
16. Lu Z., Ghosh S., Wang Z., and Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4 (2003) 499-515
17. Manes S., Mira E., Barbacid M.M., Cipres A., Fernandez-Resa P., Buesa J.M., et al. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. Journal of Biological Chemistry 272 (1997) 25706-25712
18. Muller D., Wolf C., Abecassis J., Millon A., Bronner G., Rouyer N., et al. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Research 53 (1993) 165-169
19. Muramatsu T., and Miyauchi T. Basigin (CD147): A multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histology and Histopathology 18 (2003) 981-987
20. Nabeshima K., Suzumiya J., Nagano M., Ohshima K., Toole B.P., Tamura K., et al. EMMPRIN, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. Journal of Pathology 202 (2004) 341-551
21. Pang A., Au W.Y., and Kwong Y.L. Caveolin-1 gene is coordinately regulated with the multidrug resistance 1 gene in normal and leukemic bone marrow. Leukemia Research 28 9 (2004) 973-977
22. Park S.S., Kim J.E., Kim Y.A., Kim Y.C., and Kim S.W. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 47 6 (2005) 625-630
23. Pei D., Majmudar G., and Weiss S.J. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. Journal of Biological Chemistry 269 (1994) 25849-25855
24. Pei D., and Weiss S.J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375 (1995) 244-247
25. Reimers N., Zafrakas K., Assmann V., Egen C., Riethdorf L., Riethdorf S., et al. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Clinical Cancer Research 10 10 (2004) 3422-3428
26. Rosenthal E.L., Zhang W., Talbert M., Raisch K.P., and Peters G.E. Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro. Molecular Cancer Research 3 4 (2005) 195-202
27. Sloan E.K., Stanley K.L., and Anderson R.L. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 23 (2004) 7893-7897
28. Song B., Tang J.W., Wang B., Cui X.N., Hou L., Sun L., et al. Identify lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines using gene chip. World Journal of Gastroenterology 11 10 (2005) 1463-1472
29. Sun J., and Hemler M.E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Research 61 (2001) 2276-2281
30. Sunaga N., Miyajima K., Suzuki M., Sato M., White M.A., Ramirez R.D., et al. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Research 64 (2004) 4277-4285
31. Tan W., Rouen S., Barkus K.M., Dremina Y.S., Hui D., Christianson J.A., et al. Nerve growth factor blocks the glucose-induced down-regulation of caveolin-1 expression in Schwann cells via p75 neurotrophin receptor signaling. Journal of Biological Chemistry 278 25 (2003) 23151-23162
32. Tang W., and Hemler M.E. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering. Journal of Biological Chemistry 279 (2004) 11112-11118
33. Tang W., Chang S.B., and Hemler M.E. Links between CD147 function, glycosylation, and caveolin-1. Molecular Biology of the Cell 15 9 (2004) 4043-4050
34. Urbanski S.J., Edwards D.R., Maitland A., Leco K.J., Watson A., and Kossakowska A.E. Expression of metalloproteinases and their inhibitors in primary carcinomas. British Journal of Cancer 66 (1992) 1188-1194
35. Wiechen K., Diatchenko L., Agoulnik A., Scharff K.M., Schober H., Arlt K., et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. American Journal of Pathology 159 5 (2001) 1635-1643
36. Wiechen K., Sers C., Agoulnik A., Arlt K., Dietel M., Schlag P.M., et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. American Journal of Pathology 158 3 (2001) 833-839
37. Williams T.M., Hassan G.S., Li J., Cohen A.W., Medina F., Frank P.G., et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: Genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. Journal of Biological Chemistry 280 26 (2005) 25134-25145
38. Yoshida S., Shibata M., Yamamoto S., Hagihara M., Asai N., and Takahashi M. Homo-oligomer formation by basigin, an immunoglobulin superfamily member, via its N-terminal immunoglobulin domain. European Journal of Biochemistry 267 (2000) 4372-4380
39. Zhang W., Razani B., Altschuler Y., Bouzahzah B., Mostov K.E., Pestell R.G., et al. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Journal of Biological Chemistry 275 (2000) 20717-20725